Jonathan G Drachman, MD - Seattle Genetics Inc
Seagen, now part of Pfizer, is a global biotechnology company based in Bothell, WA, dedicated to revolutionizing cancer care through the development of transformative therapies that significantly impact patients' lives. With a focus on antibody-drug conjugates, Seagen has been a pioneer in novel cancer therapeutics for over 20 years, committed to addressing challenging clinical needs with safe and effective solutions.
Driven by a mission to make a real difference for those affected by cancer, Seagen's research efforts are dedicated to advancing innovative therapies for both solid tumors and blood-related cancers. The company's culture emphasizes integrity, collaboration, and diversity, uniting a global team of scientists, clinicians, advocates, and innovators in the shared goal of transforming cancer care.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.